@karinstraathof
Associate Professor in Tumour Immunology - UCL Cancer Institute @uclcancer Honorary Consultant Paediatric Oncology - Great Ormond Street Hospital Development and clinical translation of engineered T cells for #childhood cancer @cancergrand NexTGen
This is encouraging: a glimps of what can be achieved with CAR T cells for childhood solid tumours. Spurs on research into refining CAR T cells so they achieve lasting remissions for patients with neuroblastoma, DMG and other #childhoodcancers for which current treatments are not providing a cure.
An encouraging glimps of what can be achieved with CAR T cells for childhood solid tumours. Spurs on our research into refining CAR T cells so they achieve lasting remissions for patients with neuroblastoma, DMG and other #childhoodcancers for which current treatments are not providing a cure.
Annual reminder that #duvetknowitschristmas is the hashtag to follow this evening.
Applications are now open for The Little Princess Trust’s 2025 New Ideas Grants!
We are keen to back innovation in children’s cancer research, supporting promising ideas which may be challenging to find funding for from traditional funders.
To apply, see www.cclg.org.uk/research/ccl....
Amazing work from UCL colleagues @ojlucas.bsky.social and @zaccasimo.bsky.social pairing proliferation rates with evolutionary dynamics from scDNA-seq data 🤩
🌟 Registration is OPEN for the CCLG + TYAC Annual Conference 2025, a must-attend event for #clinical, #healthcare, and #research professionals working in children and young people's cancer.
⏰ Early bird discount for members ends 16 Jan 2025!
View the programme & register bit.ly/3H6gaTu
#CCLG2025
A new CAR-T cell therapy has delivered promising results in treating patients with an aggressive blood cancer, in findings from a clinical trial led by Prof Martin Pule and Dr Claire Roddie from UCL Cancer Institute and @uclh.bsky.social
www.ucl.ac.uk/news/2024/no...